Back to Journals » Infection and Drug Resistance » Volume 12

Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience [Corrigendum]

Authors Hassan AM, Osman HA, Mahmoud HS, Hassan MH, Hashim AKA, Ameen HH

Received 17 May 2019

Accepted for publication 17 May 2019

Published 29 May 2019 Volume 2019:12 Pages 1469—1470

DOI https://doi.org/10.2147/IDR.S216102

Download Article [PDF] 

Hassan AM, Osman HA, Mahmoud HS, et al. Infect Drug Resist. 2018;11:895–901.

On page 896, “Investigatory workup” section, first bullet point, second sentence should read from “Four milliliters of blood was taken in a plain glass tube, and after clotting, the tube was centrifuged at 3,000 rpm for 5 min. Then, the serum was separated for use in estimating liver function (including liver enzymes, albumin, bilirubin-total and direct, prothrombin time, prothrombin concentration, and INR), serum creatinine, protein:creatinine ratio, and RF . . . ” to “Two milliliters of blood was taken in citrated tubes and after centrifugation, the separated citrated plasma has been used for estimation of prothrombin time, prothrombin concentration, and INR, while the remaining two milliliters of blood was taken in a plain glass tube, and after clotting, the tube was centrifuged at 3,000 rpm for 5 min. Then, the serum was separated for use in estimating liver function (including liver enzymes, albumin, bilirubin-total and direct), serum creatinine, RF and in addition to urinary protein:creatinine ratio, all were measured . . . ” 

Following a review of our paper post-publication, we found the incorrect information for these sentences. This correction of sentences has no impact to the findings of the study. The authors apologize for this error.

Read the original article

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]